The FDA's Prescription Drug Use-Related Software (PDURS) framework marks a significant milestone for healthcare in the US.

Thousands of men in the UK with advanced hormone-sensitive prostate cancer could soon be eligible for an oral therapy – ...

Blenrep is still on sale in some ex-US markets, but brought in just $45 million last year, a fraction of GSK's projections of ...

The FDA has said it will create a rare disease innovation hub to help speed the development of new treatments and build ...

Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, ...

Ursula von der Leyen has been re-elected as president of the European Commission following a secret ballot in the European ...

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical ...

In today's podcast, brought to you by Lannett CDMO, Grant Brock, VP of operations at Lannett CDMO, and Frantz Maignan, ...

During the pharma group's first-half results update, Jennifer Taubert, chair of J&J's worldwide innovation group, said that ...

Some of these areas of particular importance to pharma include helping accelerate drug discovery, clinical trials, and more ...

A snap analysis of over 100 posts on social media from 90 HCPs relating to cancer vaccinations found on the surface the same ...

After abandoning its first initial public offering (IPO) filed in 2021, natural killer (NK) cell therapy specialist Artiva ...